{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:03:27Z","timestamp":1790643807066,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.chest.2022.08.2229","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T11:12:09Z","timestamp":1662549129000},"page":"484-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia"],"prefix":"10.1016","volume":"163","author":[{"given":"Naveed","family":"Saleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adarsh","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Arthur Chandos","family":"Snow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Ambler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishkantha","family":"Arulkumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.chest.2022.08.2229_bib1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MCP.0000000000000760","article-title":"New guidelines for severe community-acquired pneumonia","volume":"27","author":"Martin-Loeches","year":"2021","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"10.1016\/j.chest.2022.08.2229_bib2","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","article-title":"Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine","volume":"36","author":"Marik","year":"2008","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.chest.2022.08.2229_bib3","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/archinte.168.10.1034","article-title":"Use of corticosteroids in treating infectious diseases","volume":"168","author":"McGee","year":"2008","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.chest.2022.08.2229_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Group","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"27","key":"10.1016\/j.chest.2022.08.2229_bib5","doi-asserted-by":"crossref","first-page":"E756","DOI":"10.1503\/cmaj.200645","article-title":"Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis","volume":"192","author":"Ye","year":"2020","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.chest.2022.08.2229_bib6","first-page":"CD007720","article-title":"Corticosteroids for pneumonia","author":"Chen","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.chest.2022.08.2229_bib7","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00134-011-2334-x","article-title":"Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study","volume":"37","author":"Moreno","year":"2011","journal-title":"Intensive Care Medicine"},{"issue":"7","key":"10.1016\/j.chest.2022.08.2229_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/M15-0715","article-title":"Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis","volume":"163","author":"Siemieniuk","year":"2015","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.chest.2022.08.2229_bib9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/thoraxjnl-2015-206881","article-title":"British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together","volume":"70","author":"Lim","year":"2015","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.chest.2022.08.2229_bib10","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.chest.2020.07.089","article-title":"International perspective on the new 2019 American Thoracic Society\/Infectious Diseases Society of America community-acquired pneumonia guideline: a critical appraisal by a global expert panel","volume":"158","author":"Pletz","year":"2020","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.chest.2022.08.2229_bib11","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.21037\/jtd.2017.05.31","article-title":"South African guideline for the management of community-acquired pneumonia in adults","volume":"9","author":"Boyles","year":"2017","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.chest.2022.08.2229_bib12","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"7650","key":"10.1016\/j.chest.2022.08.2229_bib13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.chest.2022.08.2229_bib14","first-page":"CD007720","article-title":"Corticosteroids for pneumonia","volume":"12","author":"Stern","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.chest.2022.08.2229_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ppul.22752","article-title":"Effects of prednisolone on refractory mycoplasma pneumoniae pneumonia in children","volume":"49","author":"Luo","year":"2014","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.chest.2022.08.2229_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ppul.22574","article-title":"Efficacy of methylprednisolone in children with severe community acquired pneumonia","volume":"48","author":"Nagy","year":"2013","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.chest.2022.08.2229_bib17","first-page":"401","article-title":"Clinical efficacy of adjuvant therapy with glucocorticoids in children with lobar pneumonia caused by Mycoplasma pneumoniae","volume":"16","author":"Wu","year":"2014","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"5","key":"10.1016\/j.chest.2022.08.2229_bib18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/tropej\/fmu022","article-title":"Early treatment with corticosteroids in patients with Mycoplasma pneumoniae pneumonia: a randomized clinical trial","volume":"60","author":"Huang","year":"2014","journal-title":"J\u00a0Trop Pediatr"},{"issue":"4","key":"10.1016\/j.chest.2022.08.2229_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12519-017-0014-9","article-title":"Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children","volume":"13","author":"Shan","year":"2017","journal-title":"World J Pediatr"},{"issue":"6","key":"10.1016\/j.chest.2022.08.2229_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178022","article-title":"Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: a post-hoc exploratory analysis of a randomized controlled trial","volume":"12","author":"Ceccato","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.chest.2022.08.2229_bib21","first-page":"197","article-title":"The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin","volume":"98","author":"Wagner","year":"1956","journal-title":"Bull Johns Hopkins Hosp"},{"issue":"5840","key":"10.1016\/j.chest.2022.08.2229_bib22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bmj.4.5840.569","article-title":"Ampicillin dosage and use of prednisolone in treatment of pneumonia: co-operative controlled trial","volume":"4","author":"McHardy","year":"1972","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.chest.2022.08.2229_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1378\/chest.104.2.389","article-title":"Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia: a randomized controlled study","volume":"104","author":"Marik","year":"1993","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2022.08.2229_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study","volume":"171","author":"Confalonieri","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2022.08.2229_bib25","first-page":"91","article-title":"Effects of low-dose hydrocortisone in ICU patients with severe community-acquired pneumonia","volume":"55","author":"El-Ghamrawy","year":"2006","journal-title":"Egyptian Journal of Chest"},{"issue":"5","key":"10.1016\/j.chest.2022.08.2229_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00408-007-9020-3","article-title":"Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization","volume":"185","author":"Mikami","year":"2007","journal-title":"Lung"},{"issue":"9","key":"10.1016\/j.chest.2022.08.2229_bib27","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.200905-0808OC","article-title":"Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial","volume":"181","author":"Snijders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2022.08.2229_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4236\/pp.2011.22009","article-title":"Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings","volume":"2","author":"Sabry","year":"2011","journal-title":"Pharmacol Pharm"},{"issue":"2","key":"10.1016\/j.chest.2022.08.2229_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc10103","article-title":"Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial","volume":"15","author":"Fern\u00e1ndez-Serrano","year":"2011","journal-title":"Crit Care"},{"issue":"9782","key":"10.1016\/j.chest.2022.08.2229_bib30","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","article-title":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Meijvis","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.chest.2022.08.2229_bib31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejcdt.2013.03.009","article-title":"Adjuvant role of corticosteroids in the treatment of community-acquired pneumonia","volume":"62","author":"Nafae","year":"2013","journal-title":"Egypt J Chest Dis Tuberc"},{"issue":"9977","key":"10.1016\/j.chest.2022.08.2229_bib32","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"385","author":"Blum","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.chest.2022.08.2229_bib33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial","volume":"313","author":"Torres","year":"2015","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.chest.2022.08.2229_bib34","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/jamainternmed.2019.1438","article-title":"Effectiveness of a bundled intervention including adjunctive corticosteroids on outcomes of hospitalized patients with community-acquired pneumonia: a stepped-wedge randomized clinical trial","volume":"179","author":"Lloyd","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.chest.2022.08.2229_bib35","doi-asserted-by":"crossref","first-page":"2002535","DOI":"10.1183\/13993003.02535-2020","article-title":"Adjunctive\u00a0treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired\u00a0pneumonia: a randomised clinical trial","volume":"58","author":"Wittermans","year":"2021","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.chest.2022.08.2229_bib36","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","article-title":"Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia","volume":"48","author":"GU","year":"2022","journal-title":"Intensive Care Med"},{"issue":"36","key":"10.1016\/j.chest.2022.08.2229_bib37","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1097\/MD.0000000000001474","article-title":"Modified IDSA\/ATS minor criteria for severe community-acquired pneumonia best predicted mortality","volume":"94","author":"Li","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.chest.2022.08.2229_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2015-000091","article-title":"British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together","volume":"2","author":"Lim","year":"2015","journal-title":"BMJ Open Respir Res"},{"issue":"5","key":"10.1016\/j.chest.2022.08.2229_bib39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00134-021-06394-2","article-title":"Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis","volume":"47","author":"Chaudhuri","year":"2021","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.chest.2022.08.2229_bib40","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/cid\/ciy336","article-title":"Corticosteroids reduce mortality in patients with severe community-acquired pneumonia","volume":"67","author":"Stern","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.chest.2022.08.2229_bib41","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00134-020-06230-z","article-title":"Steroids in ARDS: more light is being shed","volume":"46","author":"Arulkumaran","year":"2020","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.chest.2022.08.2229_bib42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.chest.2022.08.2229_bib43","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/00003246-199508000-00019","article-title":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature","volume":"23","author":"Cronin","year":"1995","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.chest.2022.08.2229_bib44","doi-asserted-by":"crossref","first-page":"L678","DOI":"10.1152\/ajplung.00300.2012","article-title":"Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension","volume":"304","author":"Preston","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222037059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222037059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:49:50Z","timestamp":1757926190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369222037059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0012369222037059"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2022.08.2229","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.08.2229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}